Rapid identification of influenza antigenic variants will be critical in selecting optimal vaccine candidates and thus a key to developing an effective vaccination program. Recent studies suggest that multiple simultaneous mutations at antigenic sites accumulatively enhance antigenic drift of influenza A viruses. However, pre-existing methods on antigenic variant identification are based on analyses from individual sites. Because the impacts of these co-evolved sites on influenza antigenicity may not be additive, it will be critical to quantify the impact of not only those single mutations but also multiple simultaneous mutations or co-evolved sites. Here, we developed and applied a computational method, AntigenCO, to identify and quantify ...
The antigenic variability of influenza viruses has always made influenza vaccine development challen...
[[abstract]]Motivation: Continual and accumulated mutations in hemagglutinin (HA) protein of influen...
There still are no effective long-term protective vaccines against viruses that continuously evolve ...
Rapid identification of influenza antigenic variants will be critical in selecting optimal vaccine c...
Background: The human influenza viruses undergo rapid evolution (especially in hemagglutinin (HA), a...
H1N1 is the earliest emerging subtype of influenza A viruses with available genomic sequences, has c...
H1N1 is the earliest emerging subtype of influenza A viruses with available genomic sequences, has c...
IntroductionSeasonal influenza A H3N2 viruses are constantly changing, reducing the effectiveness of...
Influenza viruses undergo continual antigenic evolution allowing mutant viruses to evade host immuni...
Influenza viruses undergo continual antigenic evolution allowing mutant viruses to evade host immuni...
[[abstract]]Human influenza viruses cause annual epidemics due to antigenic drifts in the hemaggluti...
ABSTRACT The efficacy of current influenza vaccines requires a close antigenic match between circula...
Influenza viruses undergo continual antigenic evolution allowing mutant viruses to evade host immuni...
<div><p>The antigenic variability of influenza viruses has always made influenza vaccine development...
Seasonal influenza viruses cause substantial worldwide mortality and morbidity every year. The evolu...
The antigenic variability of influenza viruses has always made influenza vaccine development challen...
[[abstract]]Motivation: Continual and accumulated mutations in hemagglutinin (HA) protein of influen...
There still are no effective long-term protective vaccines against viruses that continuously evolve ...
Rapid identification of influenza antigenic variants will be critical in selecting optimal vaccine c...
Background: The human influenza viruses undergo rapid evolution (especially in hemagglutinin (HA), a...
H1N1 is the earliest emerging subtype of influenza A viruses with available genomic sequences, has c...
H1N1 is the earliest emerging subtype of influenza A viruses with available genomic sequences, has c...
IntroductionSeasonal influenza A H3N2 viruses are constantly changing, reducing the effectiveness of...
Influenza viruses undergo continual antigenic evolution allowing mutant viruses to evade host immuni...
Influenza viruses undergo continual antigenic evolution allowing mutant viruses to evade host immuni...
[[abstract]]Human influenza viruses cause annual epidemics due to antigenic drifts in the hemaggluti...
ABSTRACT The efficacy of current influenza vaccines requires a close antigenic match between circula...
Influenza viruses undergo continual antigenic evolution allowing mutant viruses to evade host immuni...
<div><p>The antigenic variability of influenza viruses has always made influenza vaccine development...
Seasonal influenza viruses cause substantial worldwide mortality and morbidity every year. The evolu...
The antigenic variability of influenza viruses has always made influenza vaccine development challen...
[[abstract]]Motivation: Continual and accumulated mutations in hemagglutinin (HA) protein of influen...
There still are no effective long-term protective vaccines against viruses that continuously evolve ...